West Virginia MPJE (Pharmacy Jurisprudence) Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Study for the West Virginia MPJE Exam. Includes flashcards and multiple-choice questions, each with hints and explanations. Prepare effectively for your pharmacy law exam!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.


What additional labeling requirement is there for a controlled substance filled at a central fill pharmacy?

  1. Central fill pharmacy must include its own name and a phone number

  2. Central fill pharmacy must include the retail pharmacy's name and address and a unique identifier

  3. Central fill pharmacy must include only its own DEA number

  4. Central fill pharmacy must include only the DEA number of the retail pharmacy

The correct answer is: Central fill pharmacy must include its own name and a phone number

The correct answer highlights the unique labeling requirements that apply specifically to controlled substances filled at a central fill pharmacy. When a controlled substance is dispensed from a central fill pharmacy, it is essential for patients and practitioners to clearly identify the source of the medication. This transparency is achieved by requiring the central fill pharmacy to include its own name and a phone number on the label. This way, if there are questions or concerns regarding the medication, the patient or healthcare provider can readily access the pharmacy directly responsible for filling the prescription. The inclusion of the central fill pharmacy's name and phone number is particularly crucial in case any issues arise with the medication, allowing for efficient communication regarding refills, potential side effects, or any other inquiries. The focus on ensuring that patients have not just the general retail pharmacy information, but also direct access to the pharmacy that filled the prescription, enhances patient safety and supports the dispensing process. In contrast, the other choices focus on the inclusion of different identifiers or information that may not fully satisfy the necessary requirements for transparency and direct access to the pharmacy that filled the controlled substance. These options do not adequately emphasize the importance of patient access to the filling pharmacy, which is central to safe medication practices.